Latest News
Infosys Invests in 4baseCare to Boost Healthcare Tech Offerings!
Infosys, a global leader in next-generation digital services and consulting, has announced a strategic investment of INR 8.3 crore (approximately $1 million) in 4baseCare, a promising healthcare deep-tech firm specializing in precision oncology solutions. This investment underscores Infosys’ commitment to leveraging cutting-edge technologies to address critical healthcare challenges.
About 4baseCare
Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare focuses on utilizing advanced genomics and clinical data to personalize cancer treatment. The firm employs AI and analytics to improve cancer diagnosis, treatment, and drug discovery. Their unique approach includes the development of comprehensive genomic panels that enable oncologists to select optimal targeted therapies for patients.
Precision Oncology Solutions
4baseCare’s precision oncology solutions are designed to:
- Enhance Cancer Diagnosis: By integrating diverse genomic data, the platform allows for more accurate identification of cancer types and stages.
- Personalize Treatment Plans: Utilizing AI-driven insights, the startup aims to tailor treatment strategies based on individual patient profiles.
- Accelerate Drug Discovery: The data-driven approach helps streamline the development of new cancer therapies.
Strategic Alignment with Infosys
Infosys’ investment in 4baseCare aligns with its broader strategy to foster innovation and drive digital transformation within the healthcare industry. By partnering with 4baseCare, Infosys aims to enhance its offerings and provide advanced solutions to its clients in the healthcare and life sciences sectors.
Expected Benefits of the Investment
The investment will enable Infosys to tap into 4baseCare’s expertise in precision oncology, allowing it to:
- Develop innovative healthcare solutions that can improve patient outcomes.
- Leverage advanced analytics to reduce healthcare costs through more effective treatments.
- Enhance its portfolio of services aimed at healthcare providers and institutions.
Future Prospects
This strategic move comes at a time when the Indian healthtech startup ecosystem is gaining momentum. Despite facing challenges in fundraising—having raised only $7 billion across 886 deals from 2014 to mid-2024—the sector is witnessing increased interest from investors seeking innovative solutions to pressing healthcare issues.
In recent months, 4baseCare has also made headlines by raising $6 million in its Series A funding round led by Yali Capital, demonstrating strong investor confidence in its potential.
Conclusion
Infosys’ investment in 4baseCare represents a significant step toward enhancing its capabilities in the healthcare sector, particularly in precision oncology. By combining Infosys’ technological prowess with 4baseCare’s innovative solutions, this partnership is poised to make a meaningful impact on cancer treatment and patient care. As both companies work together to advance healthcare technology, they are likely to contribute significantly to improving health outcomes and driving efficiencies within the industry.
Latest News
₹290 Crore Boost: Rozana’s Series B Funding Scales Rural Retail Network Nationwide
Rozana, India’s leading rural retail platform, has secured ₹290 crore ($35 million) in a Series B funding round led by Bertelsmann India Investments (BII), with participation from Omidyar Network India, Vivid Capital, and Tana Investment Holding. This Rozana funding brings its total capital to over ₹500 crore, fueling hyperlocal expansion in underserved rural markets. Founded in 2021 by brothers Prashant and Prateek Chauhan, the startup’s phygital model blends micro-stores, app-based ordering, and last-mile delivery to connect 5 million+ users in 12 states with brands like ITC and HUL.
The ₹290 crore investment will supercharge Rozana’s rural omnichannel retail strategy, targeting 5x growth in 18 months. Plans include adding 5,000 micro-stores in Uttar Pradesh, Bihar, and Rajasthan; AI-powered inventory tech; and new categories like groceries and electronics. By empowering 20,000+ rural micro-entrepreneurs, Rozana taps into India’s $700 billion rural retail boom, where smartphone penetration and UPI drive 12% annual growth.
This Rozana Series B milestone positions it as a frontrunner against rivals like Ninjacart, eyeing unicorn status by 2028 amid ONDC tailwinds. CEO Prashant Chauhan emphasized, “We’re building rural prosperity through accessible premium brands.” For more on Rozana funding news and rural retail trends, stay updated on India’s startup ecosystem.
Latest News
Peak XV New Funds: $1.3B Commitment for India Startup Surge 2026
Peak XV Partners has launched three new funds totaling $1.3 billion, targeting India’s booming startup ecosystem. The lineup features the $600M Surge fund (8th edition) for early-stage ventures, a $300M Growth Fund for Series B+ scaling, and a $400M Acceleration Fund for rapid portfolio expansion. This commitment arrives as India’s VC inflows rebound, with AI and fintech leading 2026 trends.
These funds build on Peak XV’s legacy of backing unicorns like Zomato and Pine Labs, offering founders capital plus strategic guidance amid post-winter recovery. Early-stage deals surged 20% last year per Tracxn, positioning Peak XV to fuel the next wave of innovation in SaaS, climate tech, and consumer plays.
For startups eyeing Peak XV new funds or Surge fund 2026 applications, this signals prime opportunities. Investors and marketers should watch for deployment updates India remains a global VC hotspot.
Latest News
D2C Brand Neeman’s Raises $4 Million for Tier 2/3 Store Expansion & Eco-Friendly Shoes
Hyderabad, January 13, 2026 Neeman’s, India’s leading D2C footwear brand famed for sustainable shoes and patented PIXLL® technology, has raised $4 million from existing investors. This funding boosts its cumulative capital past $10 million since 2015, with a post-money valuation nearing $50 million. CEO Vijay Chahoria emphasized offline retail as the “next frontier,” planning 50+ new stores in Tier 2/3 cities like Jaipur and Lucknow to blend eco-friendly innovation with hands-on customer experiences.
In India’s booming D2C ecosystem where footwear sales hit ₹1.2 lakh crore in 2025 Neeman’s targets hybrid retail amid high online CAC and 25-30% returns. Backed by vegan, machine-washable shoes priced ₹2,000-4,000, the brand leverages PIXLL® (5x more breathable than leather) for carbon-neutral comfort. Recent 5x revenue growth to ₹100 crore ARR, 1M+ pairs sold via Myntra and stores, and awards at India D2C Summit 2025 position it ahead of rivals like Paaduks.
Neeman’s offline expansion India eyes the $15B sustainable footwear market by 2028, fueled by PLI schemes, Gen Z’s 70% eco-preference (Nielsen), and Southeast Asia exports. Challenges like real estate costs are offset by data-driven inventory and omnichannel QR tech. Watch for Q1 2026 launches in Hyderabad and Bengaluru redefining D2C success through authentic, “Wear the Change” branding.
